These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10995815)

  • 1. Re: markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review.
    Hemminki K; Xu G; Le Curieux F
    J Natl Cancer Inst; 2000 Sep; 92(18):1536-7. PubMed ID: 10995815
    [No Abstract]   [Full Text] [Related]  

  • 2. Rous-Whipple Award Lecture. Nucleotide excision repair and cancer predisposition: A journey from man to yeast to mice.
    Friedberg EC
    Am J Pathol; 2000 Sep; 157(3):693-701. PubMed ID: 10980107
    [No Abstract]   [Full Text] [Related]  

  • 3. Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review.
    Berwick M; Vineis P
    J Natl Cancer Inst; 2000 Jun; 92(11):874-97. PubMed ID: 10841823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphic variation in hOGG1 and risk of cancer: a review of the functional and epidemiologic literature.
    Weiss JM; Goode EL; Ladiges WC; Ulrich CM
    Mol Carcinog; 2005 Mar; 42(3):127-41. PubMed ID: 15584022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review.
    Hung RJ; Hall J; Brennan P; Boffetta P
    Am J Epidemiol; 2005 Nov; 162(10):925-42. PubMed ID: 16221808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contributions from molecular/biochemical approaches in epidemiology to cancer risk assessment and prevention.
    Lohman PH; Morolli B; Darroudi F; Natarajan AT; Gossen JA; Venema J; Mullenders LH; Vogel EW; Vrieling H; van Zeeland AA
    Environ Health Perspect; 1992 Nov; 98():155-65. PubMed ID: 1486845
    [No Abstract]   [Full Text] [Related]  

  • 7. Mismatch repair genes matched to several new roles in cancer.
    Holzman D
    J Natl Cancer Inst; 1996 Jul; 88(14):950-1. PubMed ID: 8667424
    [No Abstract]   [Full Text] [Related]  

  • 8. Identifying functional genetic variants in DNA repair pathway using protein conservation analysis.
    Savas S; Kim DY; Ahmad MF; Shariff M; Ozcelik H
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):801-7. PubMed ID: 15159313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic structures in DNA damage responses & cancer.
    Tainer JA
    Prog Biophys Mol Biol; 2015 Mar; 117(2-3):129-133. PubMed ID: 25934179
    [No Abstract]   [Full Text] [Related]  

  • 10. SNPs: can genetic variants control cancer susceptibility?
    Webb T
    J Natl Cancer Inst; 2002 Apr; 94(7):476-8. PubMed ID: 11929943
    [No Abstract]   [Full Text] [Related]  

  • 11. The inherited susceptibility to cancer.
    Guilford P
    Cell Mol Life Sci; 2000 Apr; 57(4):589-603. PubMed ID: 11130459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New insight into the regulation of DNA nucleotide excision repair: implications for cancer development and treatment].
    Auclair Y; Rouget R; Drobetsky EA
    Med Sci (Paris); 2009; 25(6-7):555-7. PubMed ID: 19602346
    [No Abstract]   [Full Text] [Related]  

  • 13. Genomic instability and cancer: cause and effect.
    Cheng KC; Diaz MO
    Cancer Cells; 1991 May; 3(5):188-92. PubMed ID: 1679993
    [No Abstract]   [Full Text] [Related]  

  • 14. Cancer, cadmium and genome integrity.
    McMurray CT; Tainer JA
    Nat Genet; 2003 Jul; 34(3):239-41. PubMed ID: 12833042
    [No Abstract]   [Full Text] [Related]  

  • 15. Mutagen sensitivity: a genetic predisposition factor for cancer.
    Wu X; Gu J; Spitz MR
    Cancer Res; 2007 Apr; 67(8):3493-5. PubMed ID: 17440053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms in DNA repair genes and associations with cancer risk.
    Goode EL; Ulrich CM; Potter JD
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1513-30. PubMed ID: 12496039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor heterogeneity and implications for clinical practice.
    Chu E
    Oncology (Williston Park); 2014 Sep; 28(9):726, 741. PubMed ID: 25224470
    [No Abstract]   [Full Text] [Related]  

  • 18. Tumor heterogeneity is fundamental to the tumor ecosystem.
    Heppner GH; Shekhar M
    Oncology (Williston Park); 2014 Sep; 28(9):780-1. PubMed ID: 25224476
    [No Abstract]   [Full Text] [Related]  

  • 19. Tumor heterogeneity: the Lernaean hydra of oncology?
    Janiszewska M; Beca F; Polyak K
    Oncology (Williston Park); 2014 Sep; 28(9):781-2, 784. PubMed ID: 25224477
    [No Abstract]   [Full Text] [Related]  

  • 20. Markers of susceptibility and environmental cancer risk: experiences in Italy.
    Landi MT
    Med Lav; 1995; 86(3):214-21. PubMed ID: 7565280
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.